Bausch & Lomb CorpBLCOEarnings & Financial Report

NYSE · pharmaceutical industry

Bausch & Lomb is an American-Canadian eye health products company based in Vaughan, Ontario, Canada. It is one of the world's largest suppliers of contact lenses, lens care products, pharmaceuticals, intraocular lenses, and other eye surgery products. The company was founded in Rochester, New York, in 1853 by optician John Bausch and cabinet maker turned financial backer Henry Lomb. Until its sale in 2013, Bausch + Lomb was one of the oldest continually operating companies in the United States.

NextMar 31, 2026

Revenue

$1.3B

Gross Profit

N/A

Operating Profit

$95.0M

Net Profit

$-28.0M

Gross Margin

N/A

Operating Margin

7.4%

Net Margin

-2.2%

YoY Growth

7.1%

EPS

$-0.08

Financial Flow

Bausch & Lomb Corp Q3 2025 Financial Summary

Bausch & Lomb Corp reported revenue of $1.3B for Q3 2025, with a net profit of $-28.0M (-2.2% margin). Cost of goods sold was N/A, operating expenses totaled N/A.

Key Financial Metrics

Total Revenue	$1.3B
Net Profit	$-28.0M
Gross Margin	N/A
Operating Margin	7.4%
Report Period	Q3 2025

Bausch & Lomb Corp Annual Revenue by Year

Bausch & Lomb Corp annual revenue history includes year-by-year totals (for example, 2024 revenue was $4.8B).

Year	Annual Revenue
2024	$4.8B
2023	$4.1B
2022	$3.8B

Income Statement

	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Revenue	$1.17B	$1.10B	$1.22B	$1.20B	$1.28B	$1.14B	$1.28B	$1.28B
YoY Growth	17.8%	18.0%	17.5%	18.8%	9.1%	3.5%	5.1%	7.1%

Balance Sheet

	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Assets	$13.44B	$13.29B	$13.25B	$13.52B	$13.47B	$13.43B	$13.83B	$13.83B
Liabilities	$6.52B	$6.56B	$6.67B	$6.85B	$6.92B	$7.00B	$7.32B	$7.33B
Equity	$6.85B	$6.66B	$6.50B	$6.59B	$6.47B	$6.36B	$6.44B	$6.43B